首页> 外文期刊>Research policy >The allocation and effectiveness of China's R&D subsidies - Evidence from listed firms
【24h】

The allocation and effectiveness of China's R&D subsidies - Evidence from listed firms

机译:中国研发补贴的分配和有效性-来自上市公司的证据

获取原文
获取原文并翻译 | 示例
       

摘要

In this study we investigate the allocation of China's R&D subsidies and their effectiveness in stimulating business R&D investments for the population of Chinese listed firms between 2001 and 2006. With respect to subsidy allocation, we find that firm selection is mainly determined by prior grants, high quality inventions, and minority state-ownership. Market-oriented provincial governments distribute grants less frequently, and firms located in developed provinces receive grants more often. Considering effectiveness, R&D subsidies instantaneously crowd-out business R&D investment but are neutral in later periods. In 2006, one public RMB reduces business R&D investments by half an RMB. However, crowding-out is not prevalent for repeated recipients of R&D subsidies, high-tech firms, and minority state-owned firms.
机译:在本研究中,我们调查了2001年至2006年间中国R&D补贴的分配及其对刺激中国上市公司人口的企业R&D投资的有效性。关于补贴分配,我们发现公司的选择主要取决于先前的赠款,高高质量的发明和少数国家拥有的所有权。以市场为导向的省政府分配赠款的频率降低,而位于发达省份的公司则更频繁地获得赠款。考虑到有效性,R&D补贴会立即挤出业务R&D投资,但在以后阶段是中性的。 2006年,人民币1元的公共研发投入使企业的研发投资减少了一半。但是,对于反复获得研发补贴,高科技企业和少数国有企业的企业来说,挤占并不普遍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号